Olivier Delattre
机构: Inserm-Institut Curie
每年引用次数
引用次数
引用: 56,912
H-指数: 116
I10-指数 : 372
出版物: 811
[Li-Fraumeni syndrome: update, new data and guidelines for clinical management].
Dominique Stoppa-Lyonnet , Olivier Delattre , Laurence Brugières , Jean Feunteun
Bulletin Du Cancer 88 ( 6) 581 -587
36
2001
Détection des micrométastases et des cellules tumorales circulantes par les techniques de biologie moléculaire dans les tumeurs solides
Olivier Delattre , Gudrun Schleiermacher
Bulletin Du Cancer 88 ( 6)
2
2001
Prognostic value of biological markers in neuroblastoma: proposal for a methodology of analysis
Olivier Delattre , représentant les biologistes du groupe Nbl , Valérie Combaret , Jean Bénard
Bulletin Du Cancer 85 ( 3)
1998
LA FAMILLE DES TUMEURS D'EWING
Olivier Delattre , Luce Dauphinot
MTP. Médecine thérapeutique pédiatrie 1 ( 2) 139 -143
1998
Constitution d’une cohorte prospective de tumeur
Olivier Delattre , Philippe Lorimier , Rosette Lidereau , Wladimir Lazar
Bulletin Du Cancer 93 ( 5) 229 -236
2006
hSNF5/INI1 Inactivation Is Mainly Associated with Homozygous Deletions and Mitotic Recombinations in Rhabdoid Tumors
Alain Aurias , Olivier Delattre , Aline Mairal , Marie-Françoise Rousseau-Merck
Cancer Research 59 ( 13) 3152 -3156
100
1999
Targeting PI3KC2β impairs proliferation and survival in acute leukemia, brain tumours and neuroendocrine tumours
Olivier Delattre , Karl Frei , Hiroyuki Kaizawa , Michael D. Waterfield
Anticancer Research 32 ( 8) 3015 -3027
27
2012
Concordant Analysis of KRAS Status in Primary Colon Carcinoma and Matched Metastasis
Patricia De Cremoux , Olivier Delattre , Wulfran Cacheux , Véronique Girre
Anticancer Research 30 ( 10) 4229 -4235
33
2010
Actualités sur les marqueurs génétiques de cancers
Isabelle Janoueix-Lerosey , Olivier Delattre
Bulletin Du Cancer 86 ( 1) 15 -21
1999
Characterization of a novel breast cancer xenograft and the corresponding cell line derived from a BRCA2 germ-line mutation carrier patient’s tumor.
Sophie Piperno-Neumann , Nathalie Auger , Laetitia Durand , Patricia DeCremoux
Cancer Research 68 5493 -5493
2008
Inhibition of the PI3K p110α impairs cell survival, chemoresistance and invasion in human medulloblastoma cells
Michael A. Grotzer , Ana Guerreiro , Tarek Shalaby , Olivier Delattre
Molecular Cancer Therapeutics 6
2007
High frequency of subclonal ALK mutations in high risk neuroblastoma patients. A SIOPEN study
Olivier Delattre , Deborah Tweddle , Eve Lapouble , Marta Jeison
Annual General Meeting and 4th Neuroblastoma Research Symposium (SIOPEN), 24-27 November 2015
2015
Detection of micrometastases and circulating tumour cells using molecular biology technics in solid tumours
Olivier Delattre , Gudrun Schleiermacher
Bulletin Du Cancer 88 ( 6) 561 -570
14
2001
[Neurectodermal differentiation of extraskeletal myxoid chondrosarcoma: a classical feature?].
Olivier Delattre , Marie-Paule Algros , Bernadette Kantelip , Marie-Agnès Collonge-Rame
Annales De Pathologie 23 ( 3) 244 -248
4
2003
Identification of non-invasive biomarkers for treatment response in neuroblastoma by circulating miRNA profiling
Isabelle Janoueix-Lerosey , Tom Van Maerken , Olivier Delattre , Nurten Yigit
Advances in Neuroblastoma Research, Congress abstracts
2016
Erratum: Protein interaction mapping: A Drosophila case study (Genome Research (2005) 15 (376-384))
Etienne Formstecher , Sandra Aresta , Vincent Colluar , Alexandre Hamburger
Genome Research 15 ( 4)
2
2005
STAG2 mutations alter CTCF-anchored loop extrusion, reduce cis-regulatory interactions and EWSR1-FLI1 activity in Ewing sarcoma
Olivier Delattre , Olivier Delattre , Franck Tirode , Karine Laud-Duval
Cancer Cell
2021
SMARCA4-deficient rhabdoid tumours show intermediate molecular features between SMARCB1-deficient rhabdoid tumours and small cell carcinomas of the ovary, hypercalcaemic type.
Olivier Delattre , Michael C Frühwald , Dominique Ranchère , Franck Bourdeaut
The Journal of Pathology
8
2021
ERG transcription factors have a splicing regulatory function involving RBFOX2 that is altered in the EWS-FLI1 oncogenic fusion.
Xavier Rambout , Olivier Delattre , Franck Tirode , Martin Dutertre
Nucleic Acids Research 49 ( 9) 5038 -5056
9
2021
Proteomic screens for suppressors of anoikis identify IL1RAP as a promising surface target in Ewing sarcoma
Anna Prudova , Didier Surdez , Olivier Delattre , Dimiter S. Dimitrov
Cancer Discovery
23
2021